Markets › United States › NAS › BRVE

Braveheart Bio Inc

NAS:BRVEHealth Technologynasdaq_composite

$19.21+2.67%At closeAt close · Tue 20 Oct · ≈ AED 70.55 · Market cap $1.73B · Next earnings Wed 2 Dec

USD millions	FY2025
Revenue	0.0
Cost of revenue	0.0
Gross profit	0.0
Research & development	62.9
Operating expenses	65.4
Operating income	(65.4)
Interest expense	0.0
Interest income	0.7
Pre-tax income	(66.1)
Income tax	0.0
Net income	(66.1)
EPS, basic (per share)	(0.73)
EPS, diluted (per share)	(0.73)
EBITDA	(65.4)
Weighted average shares (shares)	90,038,969
Weighted average diluted shares (shares)	90,038,969